Article List

WPRIM Management System> DCMS> Chinese Journal of Urology> > 30> 1

1. Preliminary report of dosage-escalated sorafenib in patients with metastatic renal cell carcinoma	Page:18—20
2. Use of sorafenib in the treatment of advanced renal cell carcinoma: toxicity profile and management	Page:32—35
3. Relationship between sorafenib's side effects and efficacy in treatment of advanced renal cell carcinoma patients	Page:28—31
4. Clinical study of sorafenib in the treatment of Chinese patients with metastatic renal cell carcinoma	Page:10—14
5. A case report of extensively ossification renal cell carcinoma and review of literature	Page:48—50
6. Usefulness of contrast-enhanced harmonic sonography in renal cell cancer and angiomyolipoma	Page:40—43
7. Morphologic change of metastatic renal cell carcinoma treated with sorafenib:report of 2 cases	Page:36—39
8. Extraperitoneal laparoscopic radical prostatectomy	Page:51—54
9. Clinical value of 16-row multislice CT in the preoperative assessment of live kidney donor	Page:44—47
10. Predictive factors of sorafenib in the treatment of metastatic renal cell carcinoma	Page:25—27
11. Phase Ⅱ study of sorafenib as first line treatment in patients with metastatic renal cell carcinoma	Page:15—17
12. Sorafenib in combination with interferon-α-2b for the treatment of metastatic renal cell carcinoma: pre-liminary results	Page:21—24